- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/62 - Insulins
Patent holdings for IPC class C07K 14/62
Total number of patents in this class: 1028
10-year publication summary
|
103
|
78
|
87
|
86
|
98
|
90
|
82
|
71
|
66
|
45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novo Nordisk A/S | 2286 |
78 |
| Case Western Reserve University | 1824 |
57 |
| Hanmi Pharm. Co., Ltd. | 572 |
38 |
| Modernatx, Inc. | 1262 |
33 |
| Merck Sharp & Dohme LLC | 3742 |
30 |
| Eli Lilly and Company | 3848 |
26 |
| Sanofi | 4068 |
20 |
| Sanofi-Aventis Deutschland GmbH | 2627 |
18 |
| Biocon Limited | 221 |
18 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 28 |
17 |
| Merck Sharp & Dohme Corp. | 2190 |
16 |
| Dechra Limited | 113 |
16 |
| Akston Biosciences Corporation | 30 |
16 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1537 |
14 |
| Quiapeg Pharmaceuticals AB | 45 |
13 |
| Protomer Technologies, Inc. | 17 |
12 |
| Indiana University Research and Technology Corporation | 799 |
11 |
| Codexis, Inc. | 802 |
10 |
| The Trustees of Indiana University | 739 |
10 |
| GAN & Lee Pharmaceuticals Co., Ltd. | 43 |
10 |
| Other owners | 565 |